Xiaoli Liu

Xiaoli Liu

Auto-generated profile, based on publicly available information

Xiaoli Liu

Department of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Experimental Cell Research
Verified
Journal Article
Closed access
LSLiu Shuai
Liu Shuai
XLXiaoli Liu
Xiaoli Liu
FWFei Wu
Fei Wu
XZXufeng Zhang
Xufeng Zhang
HZHui Zhang
Hui Zhang
ZZZuohui Zhao
Zuohui Zhao

22 May 2026 in Medicine
Verified
Journal Article
Open access
BLBinyan Liu
Binyan Liu
HLHuimin Li
Huimin Li
MHMengdi Hao
Mengdi Hao
XLXiaoli Liu
Xiaoli Liu
DYDajin Yuan
Dajin Yuan
LDLei Ding
Lei Ding
Colorectal cancer (CRC) is characterized by high incidence and mortality rates. Early identification of high-risk CRC patients and timely intervention are crucial for reducing mortality rates. This study aims to develop a prognostic model incorporating immune-related genes using 101 machine learning algorithms. We utilized data from 630 CRC patients in The Cancer Genome Atlas Program database and the Gene Expression Omnibus database as a validation set. We identified immune-related genes from the ImmPort repository and conducted differential gene expression analysis. We developed 101 machine learning models, including random survival forest, elastic net, LASSO, Ridge regression, stepwise Cox, Coxboost, partial least squares regression for Cox, supervised principal component analysis, generalized boosted modeling, and survival support vector machines. The model with the highest mean concordance index was selected as the optimal prognostic model. The Ridge regression model demonstrated the most robust performance with a mean concordance index of 0.67. Patients with higher immune-related gene risk score (IRGRS) had significantly lower survival rates (log-rank test, P < .001). Univariate and multivariate Cox regression analyses confirmed IRGRS as an independent prognostic factor. Nomograms successfully predicted overall survival at 1, 2, and 3 years. IRGRS correlated with immune cell infiltration levels and stromal activity in the tumor microenvironment. High IRGRS scores were associated with higher tumor immune dysfunction and exclusion scores, suggesting potential differences in response to immune checkpoint inhibitors. In addition, high IRGRS patients exhibited greater sensitivity to certain chemotherapy drugs. The IRGRS score is a potent predictor of survival in CRC patients. This study offers a new perspective for CRC prognosis and supports the development of personalized treatment strategies.

13 March 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
XLXiaoli Liu
Xiaoli Liu
QYQiuxia Ye
Qiuxia Ye
MHMengdi Hao
Mengdi Hao
HLHuimin Li
Huimin Li
DYDajin Yuan
Dajin Yuan
LDLei Ding
Lei Ding